MARK CAUTHEN WILLINGHAM, MD
Medical Practice at Medical Center Blvd, Winston Salem, NC
License number
North Carolina 9701197
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
Medical Center Blvd, Winston Salem, NC 27157
Phone
(336) 716-2255
(336) 716-7595 (Fax)
(336) 716-7595 (Fax)
Personal information
See more information about MARK CAUTHEN WILLINGHAM at radaris.comName
Address
Phone
505 S South St, Gastonia, NC 28052
908 Whitney Ct, High Point, NC 27265
2396 Little Peak Creek Rd, Jefferson, NC 28640
3423 Corvair Dr, High Point, NC 27265
1451 Bare Rd, West Jefferson, NC 28694
Professional information
Mark Cauthen Willingham, Winston-Salem NC
Specialties:
Family Medicine, Pathology, Anatomic Pathology
Work:
Wake Forest Univ Baptist Med Cntr
Medical Center Blvd, Winston-Salem, NC
Medical Center Blvd, Winston-Salem, NC
Education:
Medical University of South Carolina (1969)
Dr. Mark C Willingham, Winston Salem NC - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
WAKE FOREST UNIVERSITY
Medical Center Blvd, Winston Salem 27157
(336) 716-2011 (Phone)
Medical Center Blvd, Winston Salem 27157
(336) 716-2011 (Phone)
Languages:
English
Hospitals:
WAKE FOREST UNIVERSITY
Medical Center Blvd, Winston Salem 27157
Wake Forest Baptist Medical Center
Medical Center Blvd, Winston Salem 27157
Medical Center Blvd, Winston Salem 27157
Wake Forest Baptist Medical Center
Medical Center Blvd, Winston Salem 27157
Education:
Medical School
Medical University of South Carolina
Graduated: 1969
Med University Sc Med Center
Medical University of South Carolina
Graduated: 1969
Med University Sc Med Center
Methods And Compositions For The Treatment Of Cancer
US Patent:
2012010, May 3, 2012
Filed:
Oct 27, 2011
Appl. No.:
13/282832
Inventors:
Zheng Cui - Winston-Salem NC, US
Mark C. Willingham - Winston-Salem NC, US
Mark C. Willingham - Winston-Salem NC, US
International Classification:
A61K 35/14, C40B 30/06, A61P 35/00, C12Q 1/02
US Classification:
424 9371, 435 29, 506 10
Abstract:
A method of treating cancer comprises: (a) providing allogenic or autologous white blood cells from a suitable donor; and then (b) administering the white blood cells to the subject in an amount effective to treat the cancer. Preferably the white blood cells comprise innate immune cells. Preferably the white blood cells comprise less than 10% by number of cytotoxic T lymphocytes. Preferably the white blood cells, or more particularly the innate immune cells, are preselected in vitro to kill cancer cells in vitro (for example, by collecting white blood cells from the patient and determining that the white blood cells kill cancer cells in vitro before and thereby pre-selecting the donor, before collecting a subsequent population of cells from the donor for administration).
Methods And Compositions For The Treatment Of Cancer
US Patent:
2008008, Apr 17, 2008
Filed:
Oct 11, 2007
Appl. No.:
11/870768
Inventors:
Zheng Cui - Winston-Salem NC, US
Mark Willingham - Winston-Salem NC, US
Mark Willingham - Winston-Salem NC, US
International Classification:
A61K 35/00, A61P 43/00
US Classification:
424093710
Abstract:
A method of treating cancer comprises: (a) providing allogenic or autologous white blood cells from a suitable donor; and then (b) administering the white blood cells to the subject in an amount effective to treat the cancer. Preferably the white blood cells comprise innate immune cells. Preferably the white blood cells comprise less than 10% by number of cytotoxic T lymphocytes. Preferably the white blood cells, or more particularly the innate immune cells, are preselected in vitro to kill cancer cells in vitro (for example, by collecting white blood cells from the patient and determining that the white blood cells kill cancer cells in vitro before and thereby pre-selecting the donor, before collecting a subsequent population of cells from the donor for administration).